Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206.

Journal Article (Journal Article)

LBA5019 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text].

Full Text

Duke Authors

Cited Authors

  • Rini, BI; Halabi, S; Rosenberg, J; Stadler, WM; Vaena, DA; Atkins, JN; Picus, J; Czaykowski, P; Dutcher, J; Small, EJ

Published Date

  • May 20, 2009

Published In

Volume / Issue

  • 27 / 15_suppl

Start / End Page

  • LBA5019 -

PubMed ID

  • 27961198

Pubmed Central ID

  • 27961198

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

Language

  • eng

Conference Location

  • United States